nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotaxime—SLC22A8—choroid plexus—malignant glioma	0.205	0.415	CbGeAlD
Cefotaxime—SLC15A2—choroid plexus—malignant glioma	0.178	0.361	CbGeAlD
Cefotaxime—Traumatic liver injury—Temozolomide—malignant glioma	0.044	0.0869	CcSEcCtD
Cefotaxime—Nephropathy toxic—Carmustine—malignant glioma	0.0296	0.0583	CcSEcCtD
Cefotaxime—Encephalopathy—Carmustine—malignant glioma	0.0265	0.0522	CcSEcCtD
Cefotaxime—Cholestasis—Temozolomide—malignant glioma	0.0216	0.0426	CcSEcCtD
Cefotaxime—Liver injury—Temozolomide—malignant glioma	0.0195	0.0385	CcSEcCtD
Cefotaxime—Vaginal inflammation—Temozolomide—malignant glioma	0.0164	0.0324	CcSEcCtD
Cefotaxime—Candida infection—Carmustine—malignant glioma	0.0162	0.032	CcSEcCtD
Cefotaxime—Candida infection—Temozolomide—malignant glioma	0.0157	0.0309	CcSEcCtD
Cefotaxime—Vaginal infection—Temozolomide—malignant glioma	0.0155	0.0306	CcSEcCtD
Cefotaxime—Aplastic anaemia—Temozolomide—malignant glioma	0.0154	0.0304	CcSEcCtD
Cefotaxime—SLC15A2—retina—malignant glioma	0.0136	0.0276	CbGeAlD
Cefotaxime—SLC15A2—telencephalon—malignant glioma	0.0125	0.0254	CbGeAlD
Cefotaxime—SLC22A7—brain—malignant glioma	0.0113	0.0228	CbGeAlD
Cefotaxime—SLC22A6—brain—malignant glioma	0.0109	0.022	CbGeAlD
Cefotaxime—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.0107	0.0212	CcSEcCtD
Cefotaxime—Neutropenia—Carmustine—malignant glioma	0.00996	0.0197	CcSEcCtD
Cefotaxime—SLC15A2—medulla oblongata—malignant glioma	0.00984	0.02	CbGeAlD
Cefotaxime—Neutropenia—Temozolomide—malignant glioma	0.00963	0.019	CcSEcCtD
Cefotaxime—Renal failure—Carmustine—malignant glioma	0.00934	0.0184	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.0091	0.018	CcSEcCtD
Cefotaxime—SLC15A2—midbrain—malignant glioma	0.00899	0.0182	CbGeAlD
Cefotaxime—SLC15A2—spinal cord—malignant glioma	0.00878	0.0178	CbGeAlD
Cefotaxime—Haemoglobin—Carmustine—malignant glioma	0.00857	0.0169	CcSEcCtD
Cefotaxime—Haemorrhage—Carmustine—malignant glioma	0.00853	0.0168	CcSEcCtD
Cefotaxime—Haemoglobin—Temozolomide—malignant glioma	0.00828	0.0163	CcSEcCtD
Cefotaxime—Hepatitis—Temozolomide—malignant glioma	0.00824	0.0163	CcSEcCtD
Cefotaxime—Haemorrhage—Temozolomide—malignant glioma	0.00824	0.0163	CcSEcCtD
Cefotaxime—SLC22A8—central nervous system—malignant glioma	0.00819	0.0166	CbGeAlD
Cefotaxime—Erythema multiforme—Temozolomide—malignant glioma	0.00779	0.0154	CcSEcCtD
Cefotaxime—Arrhythmia—Carmustine—malignant glioma	0.00762	0.015	CcSEcCtD
Cefotaxime—SLC15A2—central nervous system—malignant glioma	0.00712	0.0144	CbGeAlD
Cefotaxime—SLC15A2—cerebellum—malignant glioma	0.00696	0.0141	CbGeAlD
Cefotaxime—Ill-defined disorder—Temozolomide—malignant glioma	0.00666	0.0131	CcSEcCtD
Cefotaxime—Leukopenia—Carmustine—malignant glioma	0.00664	0.0131	CcSEcCtD
Cefotaxime—Angioedema—Temozolomide—malignant glioma	0.00655	0.0129	CcSEcCtD
Cefotaxime—SLC22A8—brain—malignant glioma	0.0065	0.0132	CbGeAlD
Cefotaxime—Malaise—Temozolomide—malignant glioma	0.00647	0.0128	CcSEcCtD
Cefotaxime—Convulsion—Carmustine—malignant glioma	0.00643	0.0127	CcSEcCtD
Cefotaxime—Leukopenia—Temozolomide—malignant glioma	0.00642	0.0127	CcSEcCtD
Cefotaxime—Convulsion—Temozolomide—malignant glioma	0.00622	0.0123	CcSEcCtD
Cefotaxime—Discomfort—Temozolomide—malignant glioma	0.00603	0.0119	CcSEcCtD
Cefotaxime—Thrombocytopenia—Carmustine—malignant glioma	0.00593	0.0117	CcSEcCtD
Cefotaxime—Anaphylactic shock—Temozolomide—malignant glioma	0.00585	0.0116	CcSEcCtD
Cefotaxime—Thrombocytopenia—Temozolomide—malignant glioma	0.00573	0.0113	CcSEcCtD
Cefotaxime—SLC15A2—brain—malignant glioma	0.00565	0.0115	CbGeAlD
Cefotaxime—Pain—Carmustine—malignant glioma	0.00518	0.0102	CcSEcCtD
Cefotaxime—Pain—Temozolomide—malignant glioma	0.00501	0.00988	CcSEcCtD
Cefotaxime—Feeling abnormal—Carmustine—malignant glioma	0.00499	0.00985	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Carmustine—malignant glioma	0.00495	0.00978	CcSEcCtD
Cefotaxime—Feeling abnormal—Temozolomide—malignant glioma	0.00482	0.00952	CcSEcCtD
Cefotaxime—Abdominal pain—Carmustine—malignant glioma	0.00479	0.00945	CcSEcCtD
Cefotaxime—Body temperature increased—Carmustine—malignant glioma	0.00479	0.00945	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Temozolomide—malignant glioma	0.00479	0.00945	CcSEcCtD
Cefotaxime—Urticaria—Temozolomide—malignant glioma	0.00465	0.00918	CcSEcCtD
Cefotaxime—Abdominal pain—Temozolomide—malignant glioma	0.00463	0.00913	CcSEcCtD
Cefotaxime—Body temperature increased—Temozolomide—malignant glioma	0.00463	0.00913	CcSEcCtD
Cefotaxime—Hypersensitivity—Carmustine—malignant glioma	0.00446	0.00881	CcSEcCtD
Cefotaxime—Hypersensitivity—Temozolomide—malignant glioma	0.00431	0.00851	CcSEcCtD
Cefotaxime—Diarrhoea—Carmustine—malignant glioma	0.00414	0.00818	CcSEcCtD
Cefotaxime—Pruritus—Temozolomide—malignant glioma	0.00414	0.00817	CcSEcCtD
Cefotaxime—Diarrhoea—Temozolomide—malignant glioma	0.00401	0.0079	CcSEcCtD
Cefotaxime—Vomiting—Carmustine—malignant glioma	0.00385	0.0076	CcSEcCtD
Cefotaxime—Rash—Carmustine—malignant glioma	0.00382	0.00754	CcSEcCtD
Cefotaxime—Dermatitis—Carmustine—malignant glioma	0.00382	0.00753	CcSEcCtD
Cefotaxime—Headache—Carmustine—malignant glioma	0.0038	0.00749	CcSEcCtD
Cefotaxime—Vomiting—Temozolomide—malignant glioma	0.00372	0.00735	CcSEcCtD
Cefotaxime—Rash—Temozolomide—malignant glioma	0.00369	0.00728	CcSEcCtD
Cefotaxime—Dermatitis—Temozolomide—malignant glioma	0.00369	0.00728	CcSEcCtD
Cefotaxime—Headache—Temozolomide—malignant glioma	0.00367	0.00724	CcSEcCtD
Cefotaxime—Nausea—Carmustine—malignant glioma	0.0036	0.0071	CcSEcCtD
Cefotaxime—Nausea—Temozolomide—malignant glioma	0.00348	0.00686	CcSEcCtD
